March 11, 2022 – Federal Register Recent Federal Regulation Documents

As part of its continuing effort to reduce paperwork burdens, and as required by the Paperwork Reduction Act (PRA) of 1995, the Federal Communications Commission (FCC or the Commission) invites the general public and other Federal agencies to take this opportunity to comment on the following information collection. Comments are requested concerning: Whether the proposed collection of information is necessary for the proper performance of the functions of the Commission, including whether the information shall have practical utility; the accuracy of the Commission's burden estimate; ways to enhance the quality, utility, and clarity of the information collected; ways to minimize the burden of the collection of information on the respondents, including the use of automated collection techniques or other forms of information technology; and ways to further reduce the information collection burden on small business concerns with fewer than 25 employees. The FCC may not conduct or sponsor a collection of information unless it displays a currently valid control number. No person shall be subject to any penalty for failing to comply with a collection of information subject to the PRA that does not display a valid Office of Management and Budget (OMB) control number.

The Principal Deputy Administrator of the Administration for Community Living (ACL) seeks nominations for individuals to serve on the Advisory Council to Support Grandparents Raising Grandchildren.

HRSA is publishing an updated monetary amount of the average cost of a health insurance policy as it relates to the National Vaccine Injury Compensation Program (VICP).

Findings of research misconduct have been made against Terry Magnuson, Ph.D. (Respondent), Kay M. & Van L. Weatherspoon Eminent Distinguished Professor, Department of Genetics, School of Medicine (SOM), University of North Carolina at Chapel Hill (UNC). Respondent engaged in research misconduct in research included in one (1) grant application for U.S. Public Health Service (PHS) funds, specifically National Cancer Institute (NCI), National Institutes of Health (NIH), grant application R01 CA267946-01A1. The administrative actions, including supervision from February 25, 2022-January 5, 2024, are detailed below.

The Department of Commerce (Commerce) determines that certain producers/exporters of ripe olives from Spain received countervailable subsidies during the period of review (POR), January 1, 2019, through December 31, 2019.

The Department of Commerce (Commerce) determines that Hangzhou Ailong Metal Products Co., Ltd. (Ailong) made U.S. sales of light- walled rectangular pipe and tube (LWRPT) from the People's Republic of China (China) at less than normal value during the period of review (POR) August 1, 2019, through July 31, 2020.

The Children's Bureau (CB), Administration for Children and Families (ACF), U.S. Department of Health and Human Services (HHS), is requesting a 3-year extension of the Plan for Foster Care and Adoption AssistanceTitle IV-E, (OMB#: 0970-0433, expiration 11/30/2022). This plan also incorporates the plan requirements for the optional Guardianship Assistance Program, the Title IV-E prevention services plan and the Title IV-E Kinship Navigator program. There are no changes requested to the form.

In accordance with the Paperwork Reduction Act of 1995, PHMSA invites comments on proposed revisions to Form PHMSA F 7000-1, ``Accident ReportHazardous Liquid and Carbon Dioxide Pipeline Systems,'' under Office of Management and Budget (OMB) Control No. 2137-0047; Form PHMSA F 7100.2-1, ``Annual Report for Natural and Other Gas Transmission and Gathering Pipeline Systems,'' under OMB Control No. 2137-0522; Form PHMSA F 7000-1.1, ``Annual Report for Hazardous Liquid and Carbon Dioxide Pipeline Systems,'' under OMB Control No. 2137-0614; Form PHMSA F 7100.1-1, ``Annual Report for Gas Distribution Systems,'' under OMB Control No. 2137-0629; and Forms PHMSA F 7100.1, ``Incident ReportGas Distribution Systems,'' PHMSA F 7100.2, ``Incident ReportGas Transmission and Gathering Systems,'' and PHMSA F 7100.3, ``Incident ReportLiquefied Natural Gas (LNG) Facilities,'' each under OMB Control No. 2137-0635.

On February 8, 2022, a NAFTA Binational Panel issued its Decision in the matter of Ammonium Sulphate from the United States of America (Determination on Remand). The Binational Panel remanded the Secretaria de Economia's (Economia) Third Determination on Remand and ordered Economia to issue a redetermination within 90 days.

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on February 4, 2022, under section 337 of the Tariff Act of 1930, as amended, on behalf of Zebra Technologies Corporation of Lincolnshire, Illinois and Symbol Technologies, LLC of Holtsville, New York. A supplement to the complaint was filed on February 25, 2022. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain barcode scanners, mobile computers with barcode scanning capabilities, scan engines, RFID printers, components thereof, and products containing the same by reason of infringement of certain claims of U.S. Patent No. 7,498,942 (``the '942 patent''); U.S. Patent No. 8,411,177 (``the '177 patent''); and U.S. Patent No. 10,667,219 (``the '219 patent''). The complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainants request that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and a cease and desist order.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Cancer Institute, both institutes of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this Notice to Cavalry Biosciences, Inc. of San Francisco, CA.